CN106109423A - A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof - Google Patents

A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof Download PDF

Info

Publication number
CN106109423A
CN106109423A CN201610550776.XA CN201610550776A CN106109423A CN 106109423 A CN106109423 A CN 106109423A CN 201610550776 A CN201610550776 A CN 201610550776A CN 106109423 A CN106109423 A CN 106109423A
Authority
CN
China
Prior art keywords
vistamycin
keep
stage
semi
finished product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610550776.XA
Other languages
Chinese (zh)
Inventor
李立忠
王勇
苏志强
何海忠
武晋
荣航
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANXI POWERDONE PHARMACEUTICS CO Ltd
Original Assignee
SHANXI POWERDONE PHARMACEUTICS CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANXI POWERDONE PHARMACEUTICS CO Ltd filed Critical SHANXI POWERDONE PHARMACEUTICS CO Ltd
Priority to CN201610550776.XA priority Critical patent/CN106109423A/en
Publication of CN106109423A publication Critical patent/CN106109423A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This application discloses a kind of injection Vistamycin lyophilized injectable powder, including: Vistamycin 1000g;Water for injection 2000mL;Its preparation method comprises the steps: that (1) prepares Vistamycin semi-finished product;(2) Vistamycin semi-finished product are carried out lyophilization, described lyophilization includes following three stages: in the pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, puts in freeze dryer by Vistamycin semi-finished product, keep 30 minutes, it is down to 40 DEG C again, keeps 2 hours;The sublimation drying stage: flaggy temperature is warming up to 5 DEG C~0 DEG C, and keeps 2 hours;The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin lyophilized injectable powder.The advantages such as it is high that the Vistamycin of the application has yield rate, and solubility is good, and quality is more stable, whole lyophilizing technique is the shortest, substantially reduces production cost.

Description

A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof
Technical field
The application belongs to medicine and medicine manufacture technology field, more particularly, it relates to a kind of injection sulphuric acid ribose is mould Freezing-dried powder agent and preparation method thereof.
Background technology
Vistamycin is a kind of aminoglycoside antibiotics, and antimicrobial spectrum is similar to kanamycin, and that is mould compared with card for toxicity Element is low.Vistamycin is mainly combined with bacterial ribosome 30S subunit, suppresses antibacterial synthetic protein.It is used for clinically Respiratory tract, abdominal cavity, thoracic cavity, urinary tract, skin and soft tissue, osseous tissue and eye, ear nose caused by sensitive gram negative bacilli Portion infects.
The enterobacteriaceae lactobacteriaceaes such as escherichia coli, Klebsiella, Proteus are had the most anti-by Vistamycin Bacterium activity, has faint effect to mycobacterium tuberculosis and Streptococcus, to Pseudomonas aeruginosa and anaerobe without effect.Antibacterial pair Vistamycin and kanamycin have cross resistance.In clinic Vistamycin single be administered time narrow antimicrobial spectrum, easily go out Existing bacterial resistance situation, and when Vistamycin and low molecular weight dextran administering drug combinations, increased the weight of the infringement to kidney.
Summary of the invention
An aspect according to the application, it is provided that a kind of injection Vistamycin composite freeze-dried powder agent.
To achieve these goals, the application adopts the following technical scheme that
A kind of injection Vistamycin lyophilized injectable powder, it is characterised in that described injection Vistamycin freezes Dry powder injection includes:
Vistamycin 1000 weight portion;
With water for injection, Vistamycin is dissolved to 400~600g/L;
Its preparation method comprises the steps:
(1) Vistamycin semi-finished product are prepared;
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C~4 DEG C, Vistamycin semi-finished product are put into lyophilizing In machine, keep 20~40 minutes, then be down to-45 DEG C~-35 DEG C, keep 1~3 hour;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 1~3 hour;
The parsing-desiccation stage: flaggy temperature is warming up to 30~40 DEG C, and keep 2~4 hours, obtain Vistamycin and freeze Dry powder injection;
Preferably described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, Keep 30 minutes, then to be down to-40 DEG C, keep 2 hours;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 2 hours;
The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin freeze-dried powder Agent.
A kind of injection Vistamycin lyophilized injectable powder, it is characterised in that described injection Vistamycin freezes Dry powder injection includes:
Vistamycin 1000 weight portion;
With water for injection, Vistamycin is dissolved to 800-1200g/L, preferably 1000g/L;Its preparation method bag Include following steps:
(1) Vistamycin semi-finished product are prepared;
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C~4 DEG C, Vistamycin semi-finished product are put into lyophilizing In machine, keep 20~40 minutes, then be down to-45 DEG C~-35 DEG C, keep 1~3 hour;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 1~3 hour;
The parsing-desiccation stage: flaggy temperature is warming up to 30~40 DEG C, and keep 2~4 hours, obtain Vistamycin and freeze Dry powder injection;
Preferably described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, Keep 30 minutes, then to be down to-40 DEG C, keep 2 hours;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 2 hours;
The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin freeze-dried powder Agent.
Another aspect according to the application, it is provided that the preparation side of a kind of injection Vistamycin lyophilized injectable powder Method.
The preparation method of a kind of Vistamycin lyophilized injectable powder, it is characterised in that described method comprises the steps:
(1) Vistamycin semi-finished product are prepared;
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C~4 DEG C, Vistamycin semi-finished product are put into lyophilizing In machine, keep 20~40 minutes, then be down to-45 DEG C~-35 DEG C, keep 1~3 hour;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 1~3 hour;
The parsing-desiccation stage: flaggy temperature is warming up to 30~40 DEG C, and keep 2~4 hours, obtain Vistamycin and freeze Dry powder injection;
Preferably described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, Keep 30 minutes, then to be down to-40 DEG C, keep 2 hours;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 2 hours;
The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin freeze-dried powder Agent.
Preferably, when step (2) carries out lyophilizing, when the sublimation drying stage, with constant rate of speed 4 DEG C/h be warming up to- 5 DEG C~0 DEG C.
Preferably, when step (2) carries out lyophilizing, when the parsing-desiccation stage, it is warming up to constant rate of speed 8 DEG C/h 30-40℃。
Preferably, when step (2) carries out lyophilizing, when the pre-freeze stage, it is cooled to-45 DEG C~-35 DEG C from-4 DEG C~4 DEG C Time be 1-2.5 hour.
Preferably, step (1) specifically includes:
Accurately weighing the Vistamycin of recipe quantity, be added into the water for injection of recipe quantity, stirring and dissolving is extremely Solution is clarified;Counting activated carbon again and be stirred absorption, remove activated carbon, through filtering with microporous membrane, obtained filtrate is Vistamycin semi-finished product.
Preferably, the consumption of activated carbon is 0.1%g/mL.It is to say, the consumption of activated carbon is to add in every 100mL solution Enter 0.1g activated carbon.
Preferably, herein described refer to respectively through the microporous filter membrane mistake of 0.45 μm and 0.22 μm through filtering with microporous membrane Filter.
Preferably, the time of activated carbon stirring and adsorbing is 20-40 minute.
The beneficial effect that the application can produce includes:
(1) Vistamycin lyophilized injectable powder provided herein is without while any excipient, it is ensured that good Good lyophilizing outward appearance, medication is safer.
(2) the Vistamycin lyophilized injectable powder of the application uses the pre-freeze mode of segmentation so that product rate of temperature fall Faster, the crystallization particle diameter of formation is less and homogeneous, and after lyophilizing, outward appearance is loose uniformly, solubility is more preferable.
(3) outward appearance of Vistamycin lyophilized injectable powder, solubility, content provided herein and have related substance to examine Examining result of the test to understand, compared with prior art, it is high that the Vistamycin of the application has yield rate, and solubility is good, quality The advantage such as more stable, whole lyophilizing technique is the shortest, substantially reduces production cost.
Detailed description of the invention
Below in conjunction with embodiment in detail the application is described in detail, but the application is not limited to these embodiments.
If no special instructions, the raw material in embodiments herein is all bought by commercial sources, shown in table specific as follows:
Title Effect Manufacturer Authentication code Quality standard
Vistamycin Raw material Wuxi Fu Qi pharmaceutical Co. Ltd Traditional Chinese medicines quasi-word H32020841 Chinese Pharmacopoeia
Embodiment 1
A kind of injection Vistamycin lyophilized injectable powder, including:
Vistamycin 1000g;
With 2000mL water for injection, Vistamycin is dissolved to 500g/L;
Its preparation method comprises the steps:
(1) Vistamycin semi-finished product are prepared: accurately weigh the Vistamycin of recipe quantity, be added into prescription In the water for injection of amount, stirring and dissolving to solution is clarified;Counting activated carbon again and be stirred absorption, the time is 30 minutes, activity The consumption of charcoal is 0.1%g/mL;Removing activated carbon, through 0.45 μm and the filtering with microporous membrane of 0.22 μm, obtained filtrate is i.e. For Vistamycin semi-finished product.
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, Keep 30 minutes, then be down to-40 DEG C through 1 hour, keep 2 hours;
The sublimation drying stage: flaggy temperature to-5 DEG C~0 DEG C, and keeps 3 hours with the heating rate of 4 DEG C/h;
The parsing-desiccation stage: flaggy temperature, and keeps 3 hours to 35 DEG C with the heating rate of 8 DEG C/h, obtains sulphuric acid Ribostamycin lyophilized injectable powder.
Embodiment 2
A kind of injection Vistamycin lyophilized injectable powder, including:
Vistamycin 1000g;
With 1000mL water for injection, Vistamycin is dissolved to 1000g/L;
Its preparation method comprises the steps:
(1) Vistamycin semi-finished product are prepared: accurately weigh the Vistamycin of recipe quantity, be added into prescription In the water for injection of amount, stirring and dissolving to solution is clarified;Counting activated carbon again and be stirred absorption, the time is 40 minutes, activity The consumption of charcoal is 0.1%g/mL;Removing activated carbon, through 0.45 μm and the filtering with microporous membrane of 0.22 μm, obtained filtrate is i.e. For Vistamycin semi-finished product.
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, Keep 40 minutes, then be down to-45 DEG C through 2.5 hours, keep 1 hour;
The sublimation drying stage: flaggy temperature to-5 DEG C~0 DEG C, and keeps 2 hours with the heating rate of 4 DEG C/h;
The parsing-desiccation stage: flaggy temperature, and keeps 2 hours to 40 DEG C with the heating rate of 8 DEG C/h, obtains sulphuric acid Ribostamycin lyophilized injectable powder.
Embodiment 3
A kind of injection Vistamycin lyophilized injectable powder, including:
Vistamycin 1000g;
With 2500mL water for injection, Vistamycin is dissolved to 400g/L;
Its preparation method comprises the steps:
(1) Vistamycin semi-finished product are prepared: accurately weigh the Vistamycin of recipe quantity, be added into prescription In the water for injection of amount, stirring and dissolving to solution is clarified;Counting activated carbon again and be stirred absorption, the time is 20 minutes, activity The consumption of charcoal is 0.1%g/mL;Removing activated carbon, through 0.45 μm and the filtering with microporous membrane of 0.22 μm, obtained filtrate is i.e. For Vistamycin semi-finished product.
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C, Vistamycin semi-finished product are put in freeze dryer, Keep 20 minutes, then be down to-35 DEG C through 1.5 hours, keep 3 hours;
The sublimation drying stage: flaggy temperature to-5 DEG C~0 DEG C, and keeps 1 hour with the heating rate of 4 DEG C/h;
The parsing-desiccation stage: flaggy temperature, and keeps 4 hours to 30 DEG C with the heating rate of 8 DEG C/h, obtains sulphuric acid Ribostamycin lyophilized injectable powder.
Embodiment 3
The present embodiment relates to the application Vistamycin lyophilized injectable powder outward appearance, solubility, content, has related substance to investigate Test.
Investigate group: prepare Vistamycin freeze-dried powder according to the preparation method of Example 1 and Example 2 of the present invention Agent;Embodiment 1 in patent application 201310481684.7 is used to prepare Vistamycin lyophilized injectable powder;
Inspection target: the outward appearance of product, solubility, content and have related substance.
Investigation method: content, relevant substance detecting method are Same Way, all uses the high-efficient liquid of 2010 editions States Pharmacopoeia specifications Phase chromatography measures.
Investigate result and see shown in following table:
As can be seen from the above table, the redissolution speed of Vistamycin lyophilized injectable powder provided herein is fine, clear Spend clearly, it is seen that foreign body meets regulation.
By the Vistamycin lyophilized injectable powder in the embodiment of the present application 1 and embodiment 2 and patent application 201310481684.7 lyophilized injectable powders are accelerated test, through accelerated test, i.e. investigate (40 DEG C under acceleration conditions of sample ± 2 DEG C, RH75% ± 5%) detected after 6 months, testing result is as follows:
As seen from the above table, investigating through the accelerated tests of 6 months, injection Vistamycin provided herein freezes Dry powder injection sample indices is all without notable change.
The above, be only several embodiments of the application, the application not does any type of restriction, although this Shen Please with preferred embodiment disclose as above, but and be not used to limit the application, any those skilled in the art, do not taking off In the range of technical scheme, utilize the technology contents of the disclosure above to make a little variation or modification is all equal to Effect case study on implementation, in the range of belonging to technical scheme.

Claims (10)

1. an injection Vistamycin lyophilized injectable powder, it is characterised in that described injection Vistamycin lyophilizing Injectable powder includes:
Vistamycin 1000 weight portion;
With water for injection, Vistamycin is dissolved to 400~600g/L;
Its preparation method comprises the steps:
(1) Vistamycin semi-finished product are prepared;
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C~4 DEG C, Vistamycin semi-finished product are put into freeze dryer In, keep 20~40 minutes, then be down to-45 DEG C~-35 DEG C, keep 1~3 hour;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 1~3 hour;
The parsing-desiccation stage: flaggy temperature is warming up to 30~40 DEG C, and keep 2~4 hours, obtain Vistamycin lyophilized powder Injection;
The most described lyophilization includes the three below stage:
In the pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, keep 30 minutes, then it is down to-40 DEG C, keep 2 hours;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 2 hours;
The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin lyophilized injectable powder.
2. an injection Vistamycin lyophilized injectable powder, it is characterised in that described injection Vistamycin lyophilizing Injectable powder includes:
Vistamycin 1000 weight portion;
With water for injection, Vistamycin is dissolved to 800-1200g/L, preferably 1000g/L;Its preparation method include as Lower step:
(1) Vistamycin semi-finished product are prepared;
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C~4 DEG C, Vistamycin semi-finished product are put into freeze dryer In, keep 20~40 minutes, then be down to-45 DEG C~-35 DEG C, keep 1~3 hour;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 1~3 hour;
The parsing-desiccation stage: flaggy temperature is warming up to 30~40 DEG C, and keep 2~4 hours, obtain Vistamycin lyophilized powder Injection;
The most described lyophilization includes following three stages:
In the pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, keep 30 minutes, then it is down to-40 DEG C, keep 2 hours;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 2 hours;
The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin lyophilized injectable powder.
3. the preparation method of a Vistamycin lyophilized injectable powder as claimed in claim 1 or 2, it is characterised in that institute The method of stating comprises the steps:
(1) Vistamycin semi-finished product are prepared;
(2) Vistamycin semi-finished product carrying out lyophilization, described lyophilization includes following three stages:
The pre-freeze stage: first freeze dryer flaggy temperature is down to-4 DEG C~4 DEG C, Vistamycin semi-finished product are put into freeze dryer In, keep 20~40 minutes, then be down to-45 DEG C~-35 DEG C, keep 1~3 hour;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 1~3 hour;
The parsing-desiccation stage: flaggy temperature is warming up to 30~40 DEG C, and keep 2~4 hours, obtain Vistamycin lyophilized powder Injection;
The most described lyophilization includes following three stages:
In the pre-freeze stage: first freeze dryer flaggy temperature is down to 0 DEG C, Vistamycin semi-finished product are put in freeze dryer, keep 30 minutes, then it is down to-40 DEG C, keep 2 hours;
The sublimation drying stage: flaggy temperature is warming up to-5 DEG C~0 DEG C, and keeps 2 hours;
The parsing-desiccation stage: flaggy temperature is warming up to 35 DEG C, and keep 3 hours, obtain Vistamycin lyophilized injectable powder.
The preparation method of Vistamycin lyophilized injectable powder the most according to claim 3, it is characterised in that step (2) In when carrying out lyophilizing, when the sublimation drying stage, be warming up to-5 DEG C~0 DEG C with constant rate of speed 4 DEG C/h.
The preparation method of Vistamycin lyophilized injectable powder the most according to claim 3, it is characterised in that step (2) In when carrying out lyophilizing, when the parsing-desiccation stage, be warming up to 30-40 DEG C with constant rate of speed 8 DEG C/h, preferably 35 DEG C.
The preparation method of Vistamycin lyophilized injectable powder the most according to claim 3, it is characterised in that step (2) In when carrying out lyophilizing, when the pre-freeze stage, be 1-2.5 hour from-4 DEG C~the 4 DEG C times being cooled to-45 DEG C~-35 DEG C.
7. according to the preparation method of the Vistamycin lyophilized injectable powder described in any one in claim 3-5, its feature Being, step (1) specifically includes:
Accurately weighing the Vistamycin of recipe quantity, be added into the water for injection of recipe quantity, stirring and dissolving is to solution Clarification;Adding activated carbon and be stirred absorption, remove activated carbon, through filtering with microporous membrane, obtained filtrate is sulphuric acid Ribostamycin semi-finished product.
The preparation method of Vistamycin lyophilized injectable powder the most according to claim 7, it is characterised in that activated carbon Consumption is 0.1%g/mL.
9. according to the preparation method of the Vistamycin lyophilized injectable powder described in claim 7 or 8, it is characterised in that through micro- Hole membrane filtration refers to respectively through 0.45 μm and the filtering with microporous membrane of 0.22 μm.
10. according to the preparation method of the Vistamycin lyophilized injectable powder described in claim 7 or 8, it is characterised in that activity The time of charcoal stirring and adsorbing is 20-40 minute.
CN201610550776.XA 2016-07-13 2016-07-13 A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof Pending CN106109423A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610550776.XA CN106109423A (en) 2016-07-13 2016-07-13 A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610550776.XA CN106109423A (en) 2016-07-13 2016-07-13 A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106109423A true CN106109423A (en) 2016-11-16

Family

ID=57284161

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610550776.XA Pending CN106109423A (en) 2016-07-13 2016-07-13 A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106109423A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038651A (en) * 2010-12-25 2011-05-04 山东新时代药业有限公司 Ropivacaine mesylate freeze-dried powder injection
CN103536554A (en) * 2013-10-15 2014-01-29 海南卫康制药(潜山)有限公司 Ribostamycin sulfate composition freeze-dried powder for injection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038651A (en) * 2010-12-25 2011-05-04 山东新时代药业有限公司 Ropivacaine mesylate freeze-dried powder injection
CN103536554A (en) * 2013-10-15 2014-01-29 海南卫康制药(潜山)有限公司 Ribostamycin sulfate composition freeze-dried powder for injection

Similar Documents

Publication Publication Date Title
CN101623285A (en) Cefmetazole sodium medicament and preparation method thereof
CN102525963A (en) Netilmicin sulfate lyophiled powder injection and preparation method thereof
CN104434819A (en) Aceglutamide powder injection medicine composition for injection and preparation method of medicine composition
CN104352454A (en) Sodium fusidate powder-injection pharmaceutical composition for injection and preparation method
CN106109423A (en) A kind of injection Vistamycin lyophilized injectable powder and preparation method thereof
CN104095809B (en) Clindamycin phosphate injection pharmaceutical composition and preparation method
CN102367229B (en) Ethylenediamine diaceturate compound and pharmaceutical composition thereof
CN103110616B (en) Potassium magnesium aspartate freeze-dried powder preparation for injection and preparation method of preparation
CN103951679B (en) A kind of cefoperazone sodium compound and pharmaceutical composition thereof
CN103565754B (en) The preparation method of the freeze dried powder of Calcium Folinate for injection compositions
CN102727451B (en) Cefmetazole-containing pharmaceutical composition
CN102335118B (en) Freeze-dried voriconazole micelle preparation and preparation method thereof
CN105213301B (en) Netilmicin sulfate injection and its quality control method
CN109620804B (en) Ceftriaxone sodium powder injection preparation for injection and preparation method thereof
CN116077460A (en) Ganoderan nanoparticle loaded with chemotherapeutic drugs
CN103536554A (en) Ribostamycin sulfate composition freeze-dried powder for injection
CN104490799A (en) Phloroglucinol freeze-drying composition for injection and preparation method thereof
CN105640895A (en) Cefadroxil granular preparation and preparation method thereof
CN114042048B (en) Preparation process of cefepime hydrochloride for injection
CN105748482A (en) Cefoperazone sodium and tazobactam sodium pharmaceutical composition for injection
CN105997882B (en) A kind of method preparing magnetic vesica and its application on pharmaceutical carrier
Huo et al. Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment
CN114366717B (en) Enteric solid dispersion particles based on EGCG nanoparticles, preparation method and application thereof
CN104721154A (en) Norfloxacin glutamate freeze-dried powder injection medicine composition for injection
CN104382849B (en) A kind of cefaclor dry suspension and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20161116